Inovio Pharmaceuticals (INO) stock forecast for 2022

The forecast has been updated: January 20, 2022 4:45


Inovio Pharmaceuticals stock price online today

Analyst Target Price

13.63

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Inovio Pharmaceuticals stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Inovio Pharmaceuticals stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $13.63 target price for Inovio Pharmaceuticals stock stock.

Today 200 Day Moving Average is the resistance level (7.53 $).

50 Day Moving Average is the resistance level (6.18 $).




INO Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 4.32 4.13 4.60 10.31 %
Mar 4.29 4.15 4.58 9.38 %
Apr 4.37 4.22 4.52 6.57 %
May 4.30 4.07 4.61 11.66 %
Jun 4.47 4.31 4.69 8.00 %
Jul 4.83 4.65 4.94 5.96 %
Aug 4.74 4.39 4.87 9.83 %
Sep 4.88 4.71 5.00 5.85 %
Oct 5.05 4.66 5.19 10.22 %
Nov 4.60 4.30 4.85 11.37 %
Dec 4.16 3.90 4.48 12.83 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Inovio Pharmaceuticals stock.


Inovio Pharmaceuticals overview

Inovio Pharmaceuticals Address

6769 MESA RIDGE RD., SAN DIEGO, CA, US

Market Capitalization

899 400 000 $

EBITDA

-108 041 976

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.11

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.235

Trailing PE

-

Forward PE

-

EV To Revenue

139.49

EV To EBITDA

-

52 Week High

19

52 Week Low

4.17

50 Day Moving Average

6.18

200 Day Moving Average

7.53

Shares Outstanding

210386000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Inovio Pharmaceuticals stock forecast for this year


Inovio Pharmaceuticals stock forecast for Feb 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.32. Positive monthly dynamics of the instrument is expected with 10.309% volatility is expected.

Pessimistic forecast: 4.13

Optimistic: 4.60


Inovio Pharmaceuticals stock forecast for Mar 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.29. Negative monthly dynamics of the instrument is expected with 9.381% volatility is expected.

Pessimistic forecast: 4.15

Optimistic: 4.58


Inovio Pharmaceuticals stock forecast for Apr 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.37. Positive monthly dynamics of the instrument is expected with 6.570% volatility is expected.

Pessimistic forecast: 4.22

Optimistic: 4.52


Inovio Pharmaceuticals stock forecast for May 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.30. Negative monthly dynamics of the instrument is expected with 11.660% volatility is expected.

Pessimistic forecast: 4.07

Optimistic: 4.61


Inovio Pharmaceuticals stock forecast for Jun 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.47. Positive monthly dynamics of the instrument is expected with 8.000% volatility is expected.

Pessimistic forecast: 4.31

Optimistic: 4.69


Inovio Pharmaceuticals stock forecast for Jul 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.83. Positive monthly dynamics of the instrument is expected with 5.957% volatility is expected.

Pessimistic forecast: 4.65

Optimistic: 4.94


Inovio Pharmaceuticals stock forecast for Aug 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.74. Negative monthly dynamics of the instrument is expected with 9.834% volatility is expected.

Pessimistic forecast: 4.39

Optimistic: 4.87


Inovio Pharmaceuticals stock forecast for Sep 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.88. Positive monthly dynamics of the instrument is expected with 5.854% volatility is expected.

Pessimistic forecast: 4.71

Optimistic: 5.00


Inovio Pharmaceuticals stock forecast for Oct 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 5.05. Positive monthly dynamics of the instrument is expected with 10.224% volatility is expected.

Pessimistic forecast: 4.66

Optimistic: 5.19


Inovio Pharmaceuticals stock forecast for Nov 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.60. Negative monthly dynamics of the instrument is expected with 11.374% volatility is expected.

Pessimistic forecast: 4.30

Optimistic: 4.85


Inovio Pharmaceuticals stock forecast for Dec 2022.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 4.16. Negative monthly dynamics of the instrument is expected with 12.825% volatility is expected.

Pessimistic forecast: 3.90

Optimistic: 4.48



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 123.82 (24.01.2022) -1.60 %
AbbVie Inc.
ABBV 131.98 (21.01.2022) -0.79 %
Aeterna Zentaris Inc.
AEZS 0.3556 (25.01.2022) 3.55 %
Allakos Inc.
ALLK 6.53 (25.01.2022) -4.11 %
Allogene Therapeutics, Inc.
ALLO 11.36 (25.01.2022) 0.18 %
Amgen Inc.
AMGN 225.04 (25.01.2022) -0.46 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.1 (25.01.2022) 3.00 %
Aurora Cannabis Inc.
ACB 4.21 (25.01.2022) -2.55 %
Becton Dickinson and Company
BDX 264.63 (21.01.2022) 0.25 %
Biogen Inc.
BIIB 222.31 (25.01.2022) -1.06 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.08 (21.01.2022) -5.10 %
BioNTech SE
BNTX 150.98 (24.01.2022) 2.36 %
bluebird bio, Inc.
BLUE 7.76 (25.01.2022) 0.65 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 62.46 (25.01.2022) -0.24 %
Canopy Growth Corp.
CGC 7.36 (25.01.2022) -0.54 %
Castle Biosciences, Inc.
CSTL 34.97 (25.01.2022) -1.33 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 239.46 (25.01.2022) -0.40 %
Emergent BioSolutions Inc.
EBS 46.97 (21.01.2022) 0.97 %
Exelixis, Inc.
EXEL 18.21 (25.01.2022) -1.67 %
G1 Therapeutics, Inc.
GTHX 9.6 (25.01.2022) 6.90 %
Gilead Sciences, Inc.
GILD 68.84 (25.01.2022) 0.39 %
GlaxoSmithKline plc
GSK 44.37 (25.01.2022) -0.02 %
GoodRx Holdings, Inc.
GDRX 23.95 (25.01.2022) -1.16 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.15 (25.01.2022) -1.58 %
Inovio Pharmaceuticals, Inc.
INO 4.04 (25.01.2022) 3.06 %
Johnson & Johnson
JNJ 162.97 (24.01.2022) -1.15 %
Medtronic plc.
MDT 104.17 (25.01.2022) -0.04 %
Merck & Co., Inc.
MRK 79.46 (25.01.2022) 0.80 %
Moderna, Inc.
MRNA 152.54 (25.01.2022) -3.03 %
Novartis AG
NVS 84.54 (25.01.2022) -0.69 %
Novavax, Inc.
NVAX 77.21 (25.01.2022) -2.84 %
ObsEva SA
OBSV 1.48 (25.01.2022) -1.33 %
OrganiGram Holdings Inc.
OGI 1.4 (25.01.2022) -4.11 %
Pfizer Inc.
PFE 52.54 (25.01.2022) 1.94 %
Regeneron Pharmaceuticals, Inc.
REGN 603.19 (25.01.2022) -2.94 %
Sanofi
SNY 51.4 (25.01.2022) 1.10 %
Schrodinger, Inc.
SDGR 27.59 (25.01.2022) -1.36 %
Senseonics Holdings, Inc.
SENS 2.32 (25.01.2022) -2.52 %
Sorrento Therapeutics, Inc.
SRNE 3.51 (25.01.2022) -0.71 %
Stryker Corp.
SYK 249.27 (25.01.2022) -1.05 %
Sundial Growers Inc.
SNDL 0.4764 (25.01.2022) 3.57 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.46 (24.01.2022) -0.59 %
Thermo Fisher Scientific Inc.
TMO 567.75 (25.01.2022) -1.40 %
Tilray, Inc.
TLRY 5.72 (25.01.2022) -2.05 %
UnitedHealth Group, Inc.
UNH 462.27 (24.01.2022) 0.24 %
Veeva Systems Inc.
VEEV 221.32 (25.01.2022) -2.66 %
Zomedica Corp.
ZOM 0.29 (25.01.2022) -3.33 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.5 (24.01.2022) 5.49 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.